Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.79 |
| ▸ | CA2 | P00918 | 4/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.76 |
| ▸ | HTT | P42858 | 1/20 | 0.76 |
| ▸ | DHFR | P00374 | 2/20 | 0.75 |
| ▸ | GUSB | P08236 | 1/20 | 0.71 |
| ▸ | CA12 | O43570 | 1/20 | 0.69 |
| ▸ | CA7 | P43166 | 1/20 | 0.69 |
| ▸ | CA9 | Q16790 | 1/20 | 0.69 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.65 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7697757 | 0.89 | CA1 (0.74) | CA1CA2ALDH1A1HTTDHFR | |
| SCHEMBL28558189 | 0.88 | DHFR (0.81) | CA1CA2ALDH1A1HTTDHFR | |
| SCHEMBL10113385 | 0.87 | DHFR (0.79) | CA1CA2ALDH1A1HTTDHFR | |
| SCHEMBL5380810 | 0.87 | DHFR (0.79) | CA1CA2ALDH1A1DHFRGUSB | |
| SCHEMBL10113348 | 0.87 | DHFR (0.70) | CA1CA2ALDH1A1HTTDHFR | |
| SCHEMBL7694042 | 0.86 | ALDH1A1 (1.00) | CA1CA2ALDH1A1HTTDHFR | |
| SCHEMBL7695774 | 0.86 | CA1 (0.70) | CA1CA2ALDH1A1HTTDHFR | |
| SCHEMBL28555966 | 0.86 | DHFR (0.77) | CA1CA2ALDH1A1HTTDHFR | |
| SCHEMBL28555968 | 0.86 | DHFR (0.77) | CA1CA2ALDH1A1HTTDHFR | |
| SCHEMBL28562281 | 0.86 | DHFR (0.77) | CA1CA2ALDH1A1HTTDHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025215108-A1 | DUAL G9A/GSK-3ß INHIBITORS | UNIVERSITAT DE BARCELONA (ES) | 2025-10-16 | — | — | WO | claimed |
| CN-116814794-A | Biosensor adopting triple amplification strategy and combining fluorescence and electrochemical detection | 北京化工大学 | 2023-09-29 | — | — | CN | claimed |
| CN-115927294-A | U-TaqMan probe, primer, kit, method and application thereof for quantitative detection of coding and non-coding RNA | 重庆医科大学国际体外诊断研究院 | 2023-04-07 | — | — | CN | claimed |
| WO-2025215108-A1 | DUAL G9A/GSK-3ß INHIBITORS | UNIVERSITAT DE BARCELONA (ES) | 2025-10-16 | — | — | WO | disclosed |
| US-20240401121-A1 | UNIVERSAL HAIRPIN PRIMER SYSTEM FOR QUANTIFICATION OF MICRORNA | THE UNIVERSITY OF CHICAGO | 2024-12-05 | — | — | US | disclosed |
| EP-3886555-B1 | ROW UNIT FOR AGRICULTURAL IMPLEMENT, AGRICULTURAL IMPLEMENT COMPRISING SUCH ROW UNIT AND METHOD OF SETTING DRILLING DEPTH | VAEDERSTAD HOLDING AB (SE) | 2024-10-30 | — | — | EP | disclosed |
| US-12102028-B2 | Row unit for agricultural implement, agricultural implement comprising such row unit and method of setting drilling depth | VÄDERSTAD HOLDING AB (SE) | 2024-10-01 | — | — | US | disclosed |
| EP-4331557-A1 | RADICALLY POLYMERIZABLE COMPOSITION COMPRISING A REDOX INITIATOR SYSTEM BASED ON DIHYDROPYRIDINES | Ivoclar Vivadent AG (LI) | 2024-03-06 | — | — | EP | disclosed |
| US-20230402511-A1 | SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE | FUJI ELECTRIC CO., LTD. (JP) | 2023-12-14 | — | — | US | disclosed |
| CN-116814794-A | Biosensor adopting triple amplification strategy and combining fluorescence and electrochemical detection | 北京化工大学 | 2023-09-29 | — | — | CN | disclosed |
| US-11705780-B2 | Generalized jet-effect and generalized generator | SOLITON HOLDINGS CORPORATION, DELAWARE CORPORATION (US) | 2023-07-18 | — | — | US | disclosed |
| US-20090324580-A1 | Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases | CENIX BIOSCIENCE GMBH (DE) | 2009-12-31 | — | — | US | disclosed |
| US-20090324580-A1 | Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases | CENIX BIOSCIENCE GMBH (DE) | 2009-12-31 | — | — | US | disclosed |
| EP-2136626-A1 | MANNICH BASE N-OXIDE DRUGS | State of Oregon acting by and through the Oregon State Board of Higher Education on behalf of the University of Oregon (US) | 2009-12-30 | — | — | EP | disclosed |
| WO-2008115499-A1 | MANNICH BASE N-OXIDE DRUGS | STATE OF OREGON ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) | 2008-09-25 | — | — | WO | disclosed |
| US-7160449-B2 | Proline chiral columns with broad chiral selectivity | VANDERBILT UNIVERSITY (US) | 2007-01-09 | — | — | US | disclosed |
| US-7160449-B2 | Proline chiral columns with broad chiral selectivity | VANDERBILT UNIVERSITY (US) | 2007-01-09 | — | — | US | disclosed |
| US-7160449-B2 | Proline chiral columns with broad chiral selectivity | VANDERBILT UNIVERSITY (US) | 2007-01-09 | — | — | US | disclosed |
| US-7141160-B2 | Chiral columns with broad chiral selectivity | V{dot over (a)}nderbilt University (US) | 2006-11-28 | — | — | US | disclosed |
| US-20050092686-A1 | Proline chiral columns with broad chiral selectivity | LI, TINGYU | 2005-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090324580-A1 | Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases | SCARB1, MSR1, HAVCR2 | CA1 4872/4885CA2 4782/4885ALDH1A1 511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.